The system produces results within minutes without the need for an eye specialist or dilating a patient’s pupils.
An Israeli health tech company and a U.S. medical distributor are partnering to make rapid diabetic eye screenings available in pharmacies and other community healthcare locations across the United States.
AEYE Health, which develops artificial intelligence tools for retinal diagnostics, has joined with Ford Medical, a distributor that works with non-hospital care providers.
Their initiative will roll out AEYE-DS, an FDA-cleared autonomous AI system that works with a portable retinal camera to detect diabetic retinopathy—one of the leading causes of vision loss among working-age adults.
